Collaborative Pathology Managed Service Contract on behalf of Calderdale and Huddersfield NHS Foundation Trust, Leeds Teaching Hospitals NHS Trust and Mid Yorkshire NHS Trust

A Tender Notice
by LEEDS TEACHING HOSPITALS NHS TRUST (ON BEHALF OF THE COLLABORATIVE-SEE BELOW)

Source
Find a Tender
Type
Contract (Services)
Duration
14 year
Value
£475M
Sector
HEALTH
Published
21 Sep 2021
Delivery
To 18 Nov 2037 (est.)
Deadline
20 Oct 2021 11:00

Concepts

Location

United Kingdom:

Geochart for 3 buyers and 0 suppliers

Description

Calderdale and Huddersfield NHS Foundation Trust (CHFT), Leeds Teaching Hospitals NHS Trust (LTHT) and The Mid Yorkshire Hospitals NHS Trust (MYHT) (The “Collaborative”) are undertaking a competitive dialogue procurement exercise to select a managed service provider to supply The Collaborative’s Pan Pathology Managed Service (lot 1) and Cellular Pathology (lot 2). The provider for lot 2 may be the same provider or a different provider. The procurement exercise is intended to result in a managed service which provides a flexible, quality and patient focused innovative service in line with best practice ensuring The Collaborative meets the needs of its patients. The Collaborative wants to partner with a managed service provider to: • underpin the ambition of The Collaborative as an exemplar Pathology Service now and in the future • keep pace and evolve with the rapidly changing dynamics of delivering Pathology Services The procurement exercise is intended to find a provider who will: • Provide a state-of-the-art solution which can support the requirements today and in the future ensuring there is flexibility to adopt innovative solutions during the term of the contract; • Provide a solution that meets the quality and speed of testing required by our patients and clinicians and which meets local and national turnaround times; • Deploy and expand Point of Care testing in hospitals and primary care and self-testing at home; • Facilitate cross site working and consistent processes to allow flexibility across The Collaborative; • Support the transformational plans across the trusts, offering the flexibility of solution to support any consolidation of testing between laboratories; • Work with a provider of Cellular pathology (lot 2) (which may be the same provider or a different provider). The intended outcome of the procurement exercise is to contract with a provider who agrees to the contract evolving during its life. This will require on-going assessment, implementation of innovative changes and collaborative working with the provider and potential sub-contractors over the life of the contract. The way the service looks at the end of the contract will likely be very different to the initial implementation. Further details as to the contract structure for lot 1 and 2, as well as potential future services are set out in the Descriptive Document.

Lot Division

1 Blood Sciences, Specialist Testing, Microbiology, Automation and Programme Management
  • Value: £427M

Blood Sciences, Specialist Testing, Microbiology, Automation and Programme Management

2 Cellular Pathology
  • Value: £48M

Cellular Pathology

CPV Codes

  • 85111800 - Pathology services

Indicators

  • This is a one-off contract (no recurrence)
  • Renewals are not available.

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

Domains